Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy
Clin. transl. oncol. (Print)
; 14(12): 891-895, dic. 2012.
Article
in English
| IBECS
| ID: ibc-127018
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
The gamma-delta (γδ) T-cells are a subset of T-lymphocytes characterized by the presence of a surface antigen recognition complex type 2. Those γδ T-cells represent 2-5 % of peripheral T-cells only, but they are common in organs and mucosae, acting as a first defense system in the entries to the organism. The γδ T-cells take part on immune response by direct cytolysis, development of memory phenotypes, and modulation of immune cells, and they have been implied in autoimmune disorders, immune deficiencies, infections, and tumor diseases. We reported the role of γδ T-cells in oncology, focusing in their potential applications for cancer treatment. Experimental designs and clinical trials in the treatment of solid malignancies are extensively reviewed (AU)
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
T-Lymphocytes
/
Receptors, Antigen, T-Cell, gamma-delta
/
Neoplasms
Limits:
Humans
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2012
Document type:
Article
Institution/Affiliation country:
University Hospital Arnau de Vilanova/Spain